- New ICH M13a guidance on BE analysis jag009 2025-10-17 21:04
- ICH M13A (EMA, FDA, HC) Helmut 2025-10-18 12:24
- Can we administer generic drug as concomitant in patient based PK study narra1813 2025-10-14 13:20
- Guideline on the requirements for demonstrating Therapeutic equivalence between orally inhaled products (OIP) for asthma qualityassurance 2025-09-25 07:41
- Lupron shelf life or expiration date Achievwin 2025-08-08 12:25
- Lupron shelf life or expiration date Helmut 2025-08-10 07:18
- Lupron shelf life or expiration date Achievwin 2025-08-11 14:45
- Shelf-life 🇦🇹 🇳🇿 (similar in 🇪🇺?) Helmut 2025-08-11 15:48
- Shelf-life 🇦🇹 🇳🇿 (similar in 🇪🇺?) Achievwin 2025-08-14 12:09
- Shelf-life (≠ Lupron!) Helmut 2025-08-14 15:25
- Shelf-life 🇦🇹 🇳🇿 (similar in 🇪🇺?) Achievwin 2025-08-14 12:09
- Shelf-life 🇦🇹 🇳🇿 (similar in 🇪🇺?) Helmut 2025-08-11 15:48
- Lupron shelf life or expiration date Achievwin 2025-08-11 14:45
- Lupron shelf life or expiration date Helmut 2025-08-10 07:18
- Canada Implementation of ICH M13A BE guideline jag009 2025-08-14 14:55
- Comparator (formerly ‘reference product’) in BE Helmut 2025-08-01 08:41
- Hydroxy urea RLD selection for EMA submission Praful Rane 2025-07-29 11:08
- No RLD in the EEA Helmut 2025-07-29 12:36
- Different comparator batches jansari 2025-07-10 17:40
- Different comparator batches jansari 2025-07-11 07:17
- Different comparator batches Pharma_88 2025-07-11 08:44
- Different comparator batches dshah 2025-07-29 08:37
- Different comparator batches jansari 2025-07-11 07:17
- EMA: Cut-off times of partial AUC? Helmut 2025-07-17 12:46
- Bioequivalence Waiver for Lower Strengths of a BCS Class IV Drug praveen_mvln 2025-07-03 14:10
- Bioequivalence Waiver for Lower Strengths of a BCS Class IV Drug dshah 2025-07-07 11:07
- Bioequivalence Waiver for Lower Strengths of a BCS Class IV Drug praveen_mvln 2025-07-11 11:26
- Bioequivalence Waiver for Lower Strengths of a BCS Class IV Drug dshah 2025-07-07 11:07
- Erythromycin Ethylsuccinate Tablet AB661 2025-04-02 11:39
- Erythromycin Ethylsuccinate Tablet dshah 2025-04-10 05:19
- BE Study for Emedastine Fumarate 2 mg SR Capsules Sunil 2025-04-08 09:29
- ICH M13A complex study designs missing data and data excluded kimhuang 2025-03-04 08:12
- ICH M13A: Two-at-a-Time Helmut 2025-03-04 09:24
- ICH M13A: Two-at-a-Time kimhuang 2025-03-07 00:46
- ICH M13A: Descriptive statistics Helmut 2025-03-07 08:45
- ICH M13A: Descriptive statistics kimhuang 2025-03-08 05:55
- ICH M13A: Descriptive statistics Helmut 2025-03-07 08:45
- ICH M13A: Two-at-a-Time kimhuang 2025-03-07 00:46
- ICH M13A: Two-at-a-Time Helmut 2025-03-04 09:24
- 2-period full replicate design for IR formulation – EMA perspective Ankit Parikh 2024-07-11 04:58
- 2-period full replicate design for IR formulation – EMA perspective BEQool 2025-03-01 12:33
- Product Labelling Query professionalr 2025-02-18 22:01
- Product Labelling Query drgunasakaran1 2025-02-18 23:38
